BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Pacific Biosciences of California 

1380 Willow Road

Menlo Park  California  94025  U.S.A.
Phone: 650-521-8000 Fax: n/a


SEARCH JOBS







Our mission is to transform the way humankind acquires, processes and interprets data from living systems through the design, development and commercialization of innovative tools for biological research.

We have developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. Combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry and optics, we created a powerful technology platform called single molecule, real-time, or SMRT, technology. SMRT technology enables real-time analysis of biomolecules with single molecule resolution, which has the potential to transform our understanding of biological systems by providing a window into these systems that has not previously been open for scientific study.

Our initial focus is on the DNA sequencing market where we have developed and introduced a novel sequencing platform, the PacBio RS II. We believe that the PacBio RS II, which uses our proprietary SMRT technology, maintains many of the key attributes of currently available sequencing technologies while solving many of the inherent limitations of previous technologies. Our system provides long readlengths, flexibility in experimental design, fast time to result and significant ease of use. The PacBio RS II consists of an instrument platform that uses our consumables including our proprietary SMRT Cell. The system is designed to be integrated into existing laboratory workflows and information systems, which should facilitate rapid adoption. Currently, our focus is on applications for clinical, basic and agricultural research, with potential uses in molecular diagnostics, drug discovery and development, food safety, forensics, biosecurity and biofuels.

Our SMRT technology has the potential to impact scientific study beyond DNA sequencing. We, and our scientific collaborators, have published a number of peer-reviewed articles in journals including Science, Nature and Nature; Methods highlighting the power and potential applications of the SMRT platform. Potential commercial applications we have demonstrated include the study of chemical and structural modifications of DNA and the processing of RNA and; proteins. Our research and development efforts are focused on expanding our DNA sequencing capabilities and commercializing products based on these research findings. We believe that our SMRT platform represents a new paradigm in biological science, which we refer to as SMRT Biology, that has the potential to significantly impact a number of areas critical to humankind, including the diagnosis and treatment of disease as well as efforts to improve the world’s food and energy supply.


 Key Statistics


Email:
Ownership: Public

Web Site: Pacific Biosciences
Employees:
Symbol: PACB
 



Industry
Biotechnology

Segment
Start Up





 Company News
Pacific Biosciences (PACB) First Quarter 2014 Financial Results Call 4/3/2014 8:52:52 AM    More...
Pacific Biosciences (PACB) Releases Software Upgrade To Support Full-Length Transcript Sequencing And HLA Haplotype Phasing 3/31/2014 9:38:58 AM    More...
Pacific Biosciences (PACB), The Post-Hype Sleeper Of Genomics 3/3/2014 7:36:26 AM    More...
Pacific Biosciences Highlights Increased Focus On Human Genome Research At AGBT 2014; Releasing 54x Coverage Human Genome Data For De Novo Assembly 2/10/2014 9:19:42 AM    More...
Pacific Biosciences Announces Fourth Quarter 2013 Financial Results 2/5/2014 9:24:33 AM    More...
Pacific Biosciences Fourth Quarter And Year End 2013 Financial Results Call 1/13/2014 10:01:18 AM    More...
Pacific Biosciences, The Wellcome Trust Sanger Institute And Public Health England Collaborate To Finish Genomes Of 3,000 Bacterial Strains 12/3/2013 9:16:56 AM    More...
Pacific Biosciences Third Quarter 2013 Financial Results Call 10/4/2013 9:28:44 AM    More...
Pacific Biosciences Introduces New Chemistry With Longer Read Lengths to Detect Novel Features in DNA Sequence and Advance Genome Studies of Large Organisms 10/3/2013 10:05:32 AM    More...
Pacific Biosciences Strikes $75 Million Deal With Roche Diagnostics Corporation (ROG.VX) 9/25/2013 8:48:57 AM    More...
123456789

//-->